{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:25:58Z","timestamp":1776396358323,"version":"3.51.2"},"reference-count":35,"publisher":"Tech Science Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["oncol res"],"published-print":{"date-parts":[[2020,2,7]]},"abstract":"<jats:p>The purpose of this study was to investigate the efficacy and safety of drug-eluting beads transarterial chemoembolization (DEB-TACE) treatment in Chinese hepatocellular carcinoma (HCC) patients and the prognostic factors for treatment response as well as survival. A total of 275 HCC\n patients were included in this prospective study. Treatment response was assessed by modified Response Evaluation Criteria in Solid Tumors (mRECIST), and progression-free survival (PFS) as well as overall survival (OS) were determined. Liver function and adverse events (AEs) were assessed\n before and after DEB-TACE operation. Complete response (CR), partial response (PR), and objective response rate (ORR) were 22.9%, 60.7%, and 83.6%, respectively. The mean PFS was 362 (95% CI: 34.9\u2010375) days, the 6-month PFS rate was 89.4\u2009\u00b1\u20092.1%, while the mean OS\n was 380 (95% CI: 370\u2010389) days, and the 6-month OS rate was 94.4\u2009\u00b1\u20091.7%. Multivariate logistic regression revealed that portal vein invasion (<jats:italic>p<\/jats:italic>\u2009=\u20090.011) was an independent predictor of worse clinical response. Portal vein invasion (<jats:italic>p<\/jats:italic>\u2009=\u20090.040),\n previous cTACE treatment (<jats:italic>p<\/jats:italic>\u2009=\u20090.030), as well as abnormal serum creatinine level (BCr) (<jats:italic>p<\/jats:italic>\u2009=\u20090.017) were independent factors that predicted worse ORR. In terms of survival, higher Barcelona Clinic Liver Cancer (BCLC) stage (<jats:italic>p<\/jats:italic>\u2009=\u20090.029)\n predicted for worse PFS, and abnormal albumin (ALB) (<jats:italic>p<\/jats:italic>\u2009=\u20090.011) and total serum bilirubin (TBIL) (<jats:italic>p<\/jats:italic>\u2009=\u20090.009) predicted for worse OS. The number of patients with abnormal albumin, total protein (TP), TBIL, alanine aminotransferase (ALT), and aspartate\n aminotransferase (AST) were augmented at 1 week posttreatment and were similar at 1\u20103 months compared with baseline. The most common AEs were pain, fever, nausea, and vomiting, and no severe AEs were observed in this study. DEB-TACE was effective and tolerable in treating Chinese HCC\n patients, and portal vein invasion, previous cTACE treatment, abnormal BCr, ALB, and TBIL appear to be important factors that predict worse clinical outcome.<\/jats:p>","DOI":"10.3727\/096504019x15662966719585","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T01:15:21Z","timestamp":1569546921000},"page":"75-94","source":"Crossref","is-referenced-by-count":24,"title":["Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres<sup>\u00ae<\/sup> in 275 Hepatocellular Carcinoma Patients: Results From the Chinese CalliSpheres<sup>\u00ae<\/sup> Transarterial Chemoembolization in Liver Cancer (CTILC) Study"],"prefix":"10.32604","volume":"28","author":[{"given":"Junhui","family":"Sun","sequence":"first","affiliation":[{"name":"Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanhui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxi","family":"Xie","sequence":"additional","affiliation":[{"name":"Interventional Center, Xinchang People\u2019s HospitalShaoxingP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjiang","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Intervention, Jiaxing Second HospitalJiaxingP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Ningbo Medical Center, Lihuili Eastern HospitalNingboP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dedong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Liver Oncology, Ningbo No. 2 HospitalNingboP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhao","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Intervention, The First Affiliated Hospital of Wenzhou Medical UniversityWenzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinming","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Radiology, Xixi Hospital of Hangzhou, Hangzhou 6th People\u2019s HospitalHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changsheng","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Intervention, The Third Affiliated Hospital of Wenzhou Medical UniversityRuianP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiefeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beilun District People\u2019s Hospital of NingboNingboP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Radiology, Taizhou Hospital of Zhejiang ProvinceLinhaiP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihong","family":"Ying","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyi","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hangzhou Cancer HospitalHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihai","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Vascular and Interventional Radiology, The Affiliated Hospital of Medical College of Ningbo UniversityNingboP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiansong","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Radiology, Lishui Central Hospital, Lishui Hospital of Zhejiang University, The Fifth Affiliated Hospital of Wenzhou Medical UniversityLishuiP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijun","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Intervention, Dong Yang People\u2019s HospitalDongyangP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Intervention, Jinhua Central HospitalJinhuaP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Quzhou People\u2019s HospitalQuzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Intervention, Jiaxing First HospitalJiaxingP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanhai","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Digestive Endoscopy, YueQing City People\u2019s HospitalYueqingP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical UniversityHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqiang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Intervention, Zhejiang Provincial People\u2019s HospitalHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoliang","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Intervention, Zhejiang Cancer HospitalHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University College of MedicineHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University College of MedicineHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Intervention, The First Affiliated Hospital of Wenzhou Medical UniversityWenzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaping","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Intervention, Zhejiang Cancer HospitalHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Intervention, Zhejiang Cancer HospitalHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Intervention, Zhejiang Cancer HospitalHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohong","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Radiology, Shulan (Hangzhou) Hospital, Zhejiang University International HospitalHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingyang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Intervention, Zhejiang Provincial People\u2019s HospitalHangzhouP.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","reference":[{"issue":"2","key":"b1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","year":"2016","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"b2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","year":"2017","journal-title":"CA Cancer J Clin."},{"issue":"9822","key":"b3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"b4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21161","article-title":"Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma","volume":"62","year":"2012","journal-title":"CA Cancer J Clin."},{"issue":"5","key":"b5","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/gutjnl-2013-306627","article-title":"Hepatocellular carcinoma: Clinical frontiers and perspectives","volume":"63","year":"2014","journal-title":"Gut"},{"issue":"9","key":"b6","doi-asserted-by":"crossref","first-page":"a021535","DOI":"10.1101\/cshperspect.a021535","article-title":"Treatment of liver cancer","volume":"5","year":"2015","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"8","key":"b7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/1751-2980.12380","article-title":"Efficacy and safety of cTACE versus DEB-TACE in patients with hepatocellular carcinoma: A meta-analysis","volume":"17","year":"2016","journal-title":"J Dig Dis."},{"issue":"1","key":"b8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISION V study","volume":"33","year":"2010","journal-title":"Cardiovasc Intervent Radiol."},{"issue":"4","key":"b9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.transproceed.2015.12.078","article-title":"Drug-eluting bead transarterial chemoembolization as bridge therapy for hepatocellular carcinoma before living-donor liver transplantation","volume":"48","year":"2016","journal-title":"Transplant Proc."},{"key":"b10","first-page":"69","article-title":"Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma","volume":"8","year":"2016","journal-title":"Hepat Med."},{"issue":"3","key":"b11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/jgh.13147","article-title":"Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma","volume":"31","year":"2016","journal-title":"J Gastroenterol Hepatol."},{"issue":"9","key":"b12","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s00270-017-1651-z","article-title":"Image-guided transarterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for unresectable hepatic metastases from melanoma: Technique and outcomes","volume":"40","year":"2017","journal-title":"Cardiovasc Intervent Radiol."},{"issue":"6","key":"b13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5152\/dir.2017.17059","article-title":"Dual-balloon infusion microcatheter for selective drug-eluting bead transarterial chemoembolization: Initial feasibility study","volume":"23","year":"2017","journal-title":"Diagn Interv Radiol."},{"issue":"1","key":"b14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4254\/wjh.v10.i1.95","article-title":"Efficacy of intra-arterial contrast-enhanced ultrasonography during transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma","volume":"10","year":"2018","journal-title":"World J Hepatol."},{"issue":"40","key":"b15","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.3748\/wjg.v22.i40.8853","article-title":"Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma","volume":"22","year":"2016","journal-title":"World J Gastroenterol."},{"issue":"1","key":"b16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","year":"2010","journal-title":"Semin Liver Dis."},{"issue":"5","key":"b17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jvir.2012.12.003","article-title":"Multivariate analysis of prognostic factors for survival following doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma","volume":"24","year":"2013","journal-title":"J Vasc Interv Radiol."},{"issue":"2","key":"b18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/bjc.2014.199","article-title":"Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma","volume":"111","year":"2014","journal-title":"Br J Cancer"},{"issue":"6","key":"b19","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jhep.2012.07.017","article-title":"Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma","volume":"57","year":"2012","journal-title":"J Hepatol."},{"issue":"1","key":"b20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/10717544.2017.1344336","article-title":"Comparison of pharmacokinetics and drug release in tissues after transarterial chemoembolization with doxorubicin using diverse lipiodol emulsions and CalliSpheres Beads in rabbit livers","volume":"24","year":"2017","journal-title":"Drug Deliv."},{"issue":"12","key":"b21","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.jvir.2015.08.023","article-title":"Baseline and Early MR Apparent diffusion coefficient quantification as a predictor of response of unresectable hepatocellular carcinoma to doxorubicin drug-eluting bead chemoembolization","volume":"26","year":"2015","journal-title":"J Vasc Interv Radiol."},{"issue":"11","key":"b22","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.acra.2017.05.006","article-title":"Evaluation of texture analysis parameter for response prediction in patients with hepatocellular carcinoma undergoing drug-eluting bead transarterial chemoembolization (DEB-TACE) using biphasic contrast-enhanced CT image data: Correlation with liver perfusion CT","volume":"24","year":"2017","journal-title":"Acad Radiol."},{"issue":"4","key":"b23","first-page":"CR189","article-title":"Transarterial chemoembolization of Child-A hepatocellular carcinoma: Drug-eluting bead TACE (DEB TACE) vs. TACE with cisplatin\/lipiodol (cTACE)","volume":"17","year":"2011","journal-title":"Med Sci Monit."},{"issue":"4","key":"b24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1515\/raon-2015-0045","article-title":"Survival of patients with intermediate stage hepatocellular carcinoma treated with superselective transarterial chemoembolization using doxorubicin-loaded DC Bead under cone-beam computed tomography control","volume":"50","year":"2016","journal-title":"Radiol Oncol."},{"key":"b25","first-page":"1","article-title":"Comparison of triple-drug transcatheter arterial chemoembolization (TACE) with single-drug TACE using doxorubicin-eluting beads: Long-term survival in 313 patients","volume":"2017","journal-title":"AJR Am J Roentgenol."},{"issue":"6","key":"b26","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/s00330-015-3982-y","article-title":"Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma","volume":"26","year":"2016","journal-title":"Eur Radiol."},{"issue":"1","key":"b27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5604\/01.3001.0010.7542","article-title":"Prognostic ability of BCLC-B subclassification in patients with hepatocellular carcinoma undergoing transarterial chemoembolization","volume":"17","year":"2018","journal-title":"Ann Hepatol."},{"issue":"3","key":"b28","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver D. Management of hepatocellular carcinoma: An update","volume":"53","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"b29","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ejrad.2010.08.042","article-title":"High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: Long-term follow-up and clinical analysis","volume":"80","year":"2011","journal-title":"Eur J Radiol."},{"key":"b30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000368142","article-title":"Transarterial chemoembolization failure\/refractoriness: JSH-LCSGJ criteria 2014 update","volume":"87","year":"2014","journal-title":"Oncology"},{"issue":"5","key":"b31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1159\/000157322","article-title":"Acute kidney injury after transarterial chemoembolization for hepatocellular carcinoma: A retrospective analysis","volume":"26","year":"2008","journal-title":"Blood Purif."},{"issue":"2 Pt 1","key":"b32","first-page":"195","article-title":"Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: A risk-stratification analysis","volume":"16","year":"2005","journal-title":"J Vasc Interv Radiol."},{"issue":"1","key":"b33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clinre.2016.05.013","article-title":"Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis","volume":"41","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol."},{"issue":"1","key":"b34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1499-3872(15)60034-0","article-title":"Acute pancreatitis induced by transarterial chemoembolization: A single-center experience of over 1500 cases","volume":"15","year":"2016","journal-title":"Hepatobiliary Pancreat Dis Int."},{"issue":"5","key":"b35","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/hep.24246","article-title":"Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas","volume":"53","year":"2011","journal-title":"Hepatology"}],"container-title":["Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/uploads\/attached\/file\/20220622\/20220622153248_55529.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T21:38:19Z","timestamp":1733521099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v28n1\/48549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2,7]]}},"alternative-id":["0965-0407(20200207)28:1L.75;1-"],"URL":"https:\/\/doi.org\/10.3727\/096504019x15662966719585","relation":{},"ISSN":["0965-0407"],"issn-type":[{"value":"0965-0407","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,7]]}}}